Evidence map›Paper›PMID 26085345›Full record

ArticlePrenatal diagnosis2015

Global perspectives on clinical adoption of NIPT.

Mollie A Minear, Celine Lewis, Subarna Pradhan, Subhashini Chandrasekharan

Open access · bronzeAbstract read
In one paragraph

Article in Prenatal diagnosis, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 3 pooled it
28.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 3 syntheses or guidelines pooled it, 146 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. The role of information provision in economic evaluations of non-invasive prenatal testing: a systematic review.The European journal of health economics : HEPAC : health economics in prevention and care · 2019
    Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Mollie A MinearDuke Science & Society, Duke University, Durham, NC, USA.
Celine LewisGenomic and Genetic Medicine, UCL Institute of Child Health and Great Ormond Street Hospital NHS Foundation Trust, London, UK.
Subarna PradhanDuke Global Health Institute, Duke University, Durham, NC, USA.
Subhashini ChandrasekharanDuke Global Health Institute, Duke University, Durham, NC, USA.
Duke Institute for Health Innovation · USDuke University · USUniversity College London · GB

Funding

The Management and Organization Core will be administered by the Center for GenomP50HG003391 · NHGRI · DUKE UNIVERSITY · PI BESKOW, LAURA M. · 2004 to 2014
$9.9M
Intellectual Property and Access to Noninvasive Prenatal Genetic TestingR01HG007074 · NHGRI · DUKE UNIVERSITY · PI CHANDRASEKHARAN, SUBHASHINI · 2013 to 2015
$1.1M
NHGRI NIH HHS P50 HG003391NHGRI NIH HHS P50HG03391NHGRI NIH HHS R01 HG007074NHGRI NIH HHS R01HG007074
6 · The paper itself

Abstract

objectiveThe goals of this study were to assess global trends in clinical implementation of noninvasive prenatal testing (NIPT), as commercial tests are marketed increasingly worldwide, and to identify potential challenges for current or future use.

methodsWe surveyed clinicians from 46 countries about the availability of NIPT, their experiences with using NIPT, and their views on clinical, ethical, and legal issues affecting implementation in their countries.

resultsForty-nine respondents from 28 countries completed the survey. The majority reported that NIPT is available in their country (n = 43) and that they offer NIPT in their current practice (n = 38). Eighteen respondents from 14 countries reported that there are plans to introduce NIPT into routine prenatal care in their country. Test prices varied widely, ranging from $350 to $2900, and several respondents observed that high test prices limited or restricted widespread use of NIPT. Responses varied both across and within countries regarding who is offered NIPT and what the overall screening protocol should be.

conclusionThis study provides a snapshot of current use and experiences with NIPT globally. It also highlights differences in service provision that exists both across and within countries, emphasizing the need for developing national and international implementation guidelines for NIPT.

Indexed as

FemaleHumansInternationalityMaleMaternal Serum Screening TestsPregnancyPrenatal CareSurveys and Questionnaires

Identifiers

PMID26085345
PMCPMC5065727
OpenAlexW2154023327

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.